Ventyx Biosciences, Inc. (VTYX)
NASDAQ: VTYX · Real-Time Price · USD
2.850
+0.220 (8.37%)
At close: Aug 13, 2025, 4:00 PM
2.880
+0.030 (1.05%)
Pre-market: Aug 14, 2025, 8:49 AM EDT
Ventyx Biosciences Market Cap
Ventyx Biosciences has a market cap or net worth of $203.23 million as of August 14, 2025. Its market cap has increased by 26.44% in one year.
Market Cap
203.23M
Enterprise Value
4.57M
1-Year Change
26.44%
Ranking
Category
Stock Price
$2.85
Market Cap Chart
Since the IPO on October 21, 2021, Ventyx Biosciences's market cap has decreased from $782.89M to $203.23M, a decrease of -74.04%. That is a compound annual growth rate of -29.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 203.23M | 31.24% |
| Dec 31, 2024 | 154.86M | 6.21% |
| Dec 29, 2023 | 145.80M | -92.15% |
| Dec 30, 2022 | 1.86B | 85.92% |
| Dec 31, 2021 | 998.89M | 27.59% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 592.95B |
| Johnson & Johnson | 420.06B |
| AbbVie | 355.91B |
| UnitedHealth Group | 246.17B |
| AstraZeneca | 240.81B |
| Novartis AG | 234.72B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 225.22B |